[1]
V. Suryadevara, “Comparing Safety and Efficacy of Rituximab and Eculizumab in Treating Refractory Myasthenia Gravis: A Systematic Review”, Journal For International Medical Graduates, vol. 2, no. 2, Sep. 2023, doi: 10.56570/jimgs.v2i2.138.